<?xml version="1.0" encoding="UTF-8"?>
<p>Viral hepatitis is the seventh leading cause of mortality, exceeding that of HIV, tuberculosis and malaria.
 <xref rid="dyaa052-B1" ref-type="bibr">
  <sup>1</sup>
 </xref> Half of all viral hepatitis-related deaths are caused by hepatitis C virus (HCV) infection,
 <xref rid="dyaa052-B1" ref-type="bibr">
  <sup>1</sup>
 </xref> whose sequelae include hepatitis, fibrosis, cirrhosis and liver cancer.
 <xref rid="dyaa052-B1" ref-type="bibr">
  <sup>1–3</sup>
 </xref> HCV antibody (Ab) prevalence is estimated to be ∼1% for the global population,
 <xref rid="dyaa052-B4" ref-type="bibr">
  <sup>4</sup>
 </xref> in stark contrast to Egypt, which is estimated to have a prevalence of 10%
 <xref rid="dyaa052-B5" ref-type="bibr">
  <sup>5–8</sup>
 </xref>—possibly the highest prevalence worldwide.
 <xref rid="dyaa052-B8" ref-type="bibr">
  <sup>8–10</sup>
 </xref>
</p>
